The multi-identity has revealed himself yet again (though
The multi-identity has revealed himself yet again (though we already knew) and wants us to let him have it.
Happy to oblige.
There is no obligation for the company to give specifics on clinical trial sites, date of initiation of dosing, or the other things that are helpful to short sellers and their minions, in their efforts to paint every positive development as being purportedly negative.
When someone comes here trying to provoke controversy over something that is a non-issue, then they reveal their true agenda.
Thanks for coming out in the open. Now those who were wondering whether they were being overly vigilant know that in fact their suspicions were true.
10
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
New Strategic Vision for 2030 Novonesis has recently unveiled its ambitious ‘GROW’ strategy, aimed at propelling the company through significant growth and innovation until the year 2030. This strategy underscores a firm commitment to accelerating core business operations while making substantial reinvestments to ensure sustainable long-term growth. Expected Growth...
Continue Reading
blueharbor bank Reports Strong Q1 2025 Financial Performance blueharbor bank has announced its financial results for the first quarter of 2025, showcasing notable growth across various metrics. With a robust strategy focused on customer engagement and quality service, the bank recorded impressive earnings that reflect its commitment to excellence. Highlights of Financial...
Continue Reading
Better Choice Company Gains Strong Support for Major Acquisition Better Choice Company, Inc. (NYSE: BTTR), a progressive leader in pet health and wellness, has successfully secured substantial backing from its shareholders regarding its strategic initiatives. Recently, during a special meeting, shareholders overwhelmingly approved critical proposals that are set to shape...
Continue Reading
Akamai Completes Acquisition of Select Assets from Edgio Akamai Technologies, Inc. (NASDAQ: AKAM), a leading cybersecurity and cloud computing company, recently announced the successful completion of its acquisition of select assets from Edgio. This deal includes valuable customer contracts related to Edgio's expertise in content delivery and security, as well as...
Continue Reading
Uber Technologies Inc. Preparations for Q3 Earnings Uber Technologies Inc. (NYSE: UBER) is gearing up to report its third-quarter earnings soon, drawing significant attention from investors. Many are eager to see if the company can achieve ambitious financial targets set by its leadership. Strong Third-Quarter Growth Projections In the wake of a record second quarter,...
Continue Reading
